Ebola in the United Kingdom: Nurse Receives Blood Plasma of Survivors

London – Pauline Cafferkey is currently being treated with an experimental drug and blood plasma from survivor Will Pooley. But her case raises questions about disease control and Ebola in the United Kingdom. She wanted to help and is now in the hospital herself. Nevertheless, the British nurse infected with Ebola is doing well under the circumstances. “Ms Cafferkey is not feeling well but it would be fair to say that she is as well...

Continue reading

Aethlon Medical announces approval of revolutionary Ebola treatment

SAN DIEGO, PRNewswire/ — Aethlon Medical, Inc. (AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced that the United States Food and Drug Administration (FDA) has approved a clinical protocol to treat Ebola-infected individuals in the U.S. with the Aethlon Hemopurifier®. In the treatment of viral pathogens, the Hemopurifier® is a first-in-class bio-filtration device designed...

Continue reading

Experimental drug for Scottish Nurse battling Ebola

(BBC NEWS) Specialists at the Royal Free Hospital in Hampstead, where the nurse is being treated, did not name the drug. Dr Michael Jacobs said Ms Cafferkey was in isolation and was sitting up in bed, talking and reading. As the disease has no known cure and is unpredictable, Dr Jacobs said they would know more in a week’s time. He said Ms Cafferkey had agreed to all the treatments and her family had been to see her. “She’s a...

Continue reading

CDC: Lab tech may have been exposed to Ebola.

Experts say “We can’t afford these mistakes” By Steve Almasy, CNN — A lab tech from the Centers for Disease Control and Prevention will be monitored for three weeks after possibly being exposed to the Ebola virus at one of the agency’s Atlanta labs, the CDC said Wednesday. The CDC said in a written statement that a small amount of material from an experiment was mistakenly transferred from one lab to another and it...

Continue reading

Human Genome May Provide Clues into the Ebola Virus

Ramaswamy Narayanan, Ph.D., professor in the Charles E. Schmidt College of Science at Florida Atlantic University, is working to blend the power of computers with biology to use the human genome to remove much of the guesswork involved in discovering cures for diseases. In an article titled “Ebola-Associated Genes in the Human Genome: Implications for Novel Targets,” published in the current MedCrave Online Journal of Proteomics and Bioinformatics,...

Continue reading

53 Approved Drugs Identified that May Block Ebola Infection

Researchers found 53 existing drugs that may keep the Ebola virus from entering human cells, a key step in the process of infection, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and the National Institutes of Health (NIH), and published today in the Nature Press journal Emerging Microbes and Infections. Among the better known drug types shown to hinder infection by an Ebola virus model: several cancer drugs,...

Continue reading

Untested Ebola drug given to patients in Sierra Leone causes UK walkout

(The Guardian – Sarah Boseley/Freetown) Ebola patients at a treatment centre in Sierra Leone have been given a heart drug that is untested against the virus in animals and humans, a move that has been deemed reckless by one senior scientist and has prompted UK medical staff at the centre to leave. A 14-strong team of British doctors, nurses and paramedics stopped working at the Lakka treatment centre in Freetown because of their concerns...

Continue reading

Chikungunya: Another infectious disease the world is ignoring

It’s a tale scientists are tired of telling: a disease that’s been carefully watched and studied for years is suddenly infecting an unprecedented number of people while promising drugs and vaccines sit on shelved, unfunded. This time it’s not Ebola but a mosquito-borne disease called chikungunya, which causes debilitating joint pain and has infected more than 1 million people just this year. Originating in Africa, the virus has rapidly spread into...

Continue reading

GSK Ebola vaccine trial moving to wider phase in February

(Reuters) – Trials of GlaxoSmithKline’s experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information. The World Health Organization, which hosted a meeting of national regulatory authorities and ethics committees earlier this week, said they had thoroughly discussed all aspects of the proposed trials at the two-day...

Continue reading

Critically ill Doctor cured by experimental Ebola drug

A prototype anti-Ebola drug has helped a critically ill doctor from Sierra Leone, according to the latest study. The medic, who was flown to a German hospital in September with severe Ebola symptoms and discharged a month later, fully recovered. The study, published in medical journal The Lancet, has urged clinical evaluation of the treatment. The 38-year-old doctor was airlifted and transferred to Frankfurt University Hospital in September, showing...

Continue reading